Article

ONS Announces New Board at the 35th Annual Congress

The Oncology Nursing Society (ONS) has announced its 2010-2011 Board of Directors.

Other newly elected officers include Julie Eggert, RN, PhD, GNP-C, AOCN, who has assumed the role of secretary; Margaret Barton-Burke, PhD, RN, and Mary Pat Johnston, RN, MS, AOCN, who are directors-at-large; and Emma Dann, RN, MS, OCN, NE-BC, who has become a board member.

Several other members will be continuing on the Board, including Laura Fennimore, RN, MSN, who will continue on as treasurer, and Susan Schneider, PhD, RN, AOCN, FAAN, Virginia Martin, RN, MSN, AOCN, and Michele Gaguski, MSN, RN, AOCN, CHPN, APN-C, who will continue to serve as directors-at-large.

In a press statement, Brown said “This Board of Directors represents an excellent mix of oncology nurses with a diverse background in clinical practice settings, research, and academia.” He went on to say, “Our imminent challenge will be to help prepare and position our profession for the new changes associated with healthcare reform.”

The Oncology Nursing Society (ONS) has announced its 2010-2011 Board of Directors. The organization’s new president is Carlton Brown, PhD, RN, AOCN, who is an assistant professor at the University of Delaware School of Nursing, Newark, Delaware. Dr Brown has been an ONS member for more than 17 years and assumed the presidency following a 1-year term as president-elect. This selection provides further evidence that the face of nursing is truly starting to change.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.